Emerging at the UK, retatrutide, a new peptide , is creating considerable interest within the medical community regarding its potential for physique regulation. This dual GIP and GLP-1 receptor agonist looks to provide a substantial advantage over existing therapies, showing promising results in initial clinical studies . Researchers suggest its pa